{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Alzheimer+Disease+18&page=2", "query": { "condition": "Alzheimer Disease 18", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Alzheimer+Disease+18&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T08:10:00.887Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00855868", "title": "Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "florbetapir F 18", "type": "DRUG" }, { "name": "[11C]-PIB", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "55 Years to 90 Years" }, "enrollment_count": 28, "start_date": "2009-03", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2012-07-26", "last_synced_at": "2026-06-10T08:10:00.887Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00855868" }, { "nct_id": "NCT06709014", "title": "A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Early Alzheimers Disease" ], "interventions": [ { "name": "buntanetap/posiphen", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Annovis Bio Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "55 Years to 85 Years" }, "enrollment_count": 760, "start_date": "2025-02-04", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2026-05-18", "last_synced_at": "2026-06-10T08:10:00.887Z", "location_count": 78, "location_summary": "Chandler, Arizona • Phoenix, Arizona • Scottsdale, Arizona + 72 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Canoga Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06709014" }, { "nct_id": "NCT03901092", "title": "A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "flortaucipir F 18", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 242, "start_date": "2019-03-26", "completion_date": "2019-04-26", "has_results": true, "last_update_posted_date": "2020-09-09", "last_synced_at": "2026-06-10T08:10:00.887Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03901092" }, { "nct_id": "NCT02278367", "title": "Clinical Evaluation of Flortaucipir F 18", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease", "Traumatic Brain Injury", "Depression" ], "interventions": [ { "name": "Flortaucipir F18", "type": "DRUG" }, { "name": "Brain PET scan", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 179, "start_date": "2014-12", "completion_date": "2019-06-26", "has_results": true, "last_update_posted_date": "2020-09-10", "last_synced_at": "2026-06-10T08:10:00.887Z", "location_count": 5, "location_summary": "Phoenix, Arizona • New Haven, Connecticut • Las Vegas, Nevada + 2 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02278367" }, { "nct_id": "NCT01565330", "title": "A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "florbetapir F 18", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "ALL", "summary": "35 Years and older" }, "enrollment_count": 20, "start_date": "2008-03", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2012-06-18", "last_synced_at": "2026-06-10T08:10:00.887Z", "location_count": 3, "location_summary": "West Palm Beach, Florida • North East, Maryland • Clementon, New Jersey", "locations": [ { "city": "West Palm Beach", "state": "Florida" }, { "city": "North East", "state": "Maryland" }, { "city": "Clementon", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01565330" }, { "nct_id": "NCT00104013", "title": "Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "xaliproden (SR57746A)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 1455, "start_date": "2003-11", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2008-08-21", "last_synced_at": "2026-06-10T08:10:00.887Z", "location_count": 32, "location_summary": "Mesa, Arizona • Peoria, Arizona • Tucson, Arizona + 27 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00104013" }, { "nct_id": "NCT01712074", "title": "Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "PF-05212377 (SAM-760)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 186, "start_date": "2012-11", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2017-03-20", "last_synced_at": "2026-06-10T08:10:00.887Z", "location_count": 40, "location_summary": "Costa Mesa, California • Imperial, California • Rancho Mirage, California + 29 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Imperial", "state": "California" }, { "city": "Rancho Mirage", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Hamden", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01712074" }, { "nct_id": "NCT04100889", "title": "A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alzheimer Disease", "Alzheimer Disease 1", "Alzheimer Disease 2", "Alzheimer Disease 3", "Alzheimer Disease 4", "Alzheimer Disease 5", "Alzheimer Disease 6", "Alzheimer Disease 7", "Alzheimer Disease 8", "Alzheimer Disease 9, Late-Onset", "Alzheimer Disease 10", "Alzheimer Disease 11", "Alzheimer Disease 12", "Alzheimer Disease 13", "Alzheimer Disease 14", "Alzheimer Disease 15", "Alzheimer Disease 16", "Alzheimer Disease 17", "Alzheimer Disease 18", "Alzheimer Disease 19", "Alzheimer Disease, Early Onset", "Alzheimer Disease, Late Onset", "Alzheimer Disease Focal" ], "interventions": [ { "name": "No Intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "ProgenaBiome", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2020-03-02", "completion_date": "2030-07", "has_results": false, "last_update_posted_date": "2025-06-05", "last_synced_at": "2026-06-10T08:10:00.887Z", "location_count": 1, "location_summary": "Ventura, California", "locations": [ { "city": "Ventura", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04100889" }, { "nct_id": "NCT03887455", "title": "A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Early Alzheimer's Disease" ], "interventions": [ { "name": "Lecanemab IV", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Lecanemab SC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "50 Years to 90 Years" }, "enrollment_count": 1906, "start_date": "2019-03-27", "completion_date": "2029-06-30", "has_results": false, "last_update_posted_date": "2026-04-07", "last_synced_at": "2026-06-10T08:10:00.887Z", "location_count": 112, "location_summary": "Phoenix, Arizona • Sun City, Arizona • Tucson, Arizona + 84 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03887455" }, { "nct_id": "NCT01565291", "title": "A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "florbetapir F 18", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 32, "start_date": "2007-06", "completion_date": "2008-01", "has_results": true, "last_update_posted_date": "2012-05-18", "last_synced_at": "2026-06-10T08:10:00.887Z", "location_count": 3, "location_summary": "Baltimore, Maryland • North East, Maryland • Long Branch, New Jersey", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "North East", "state": "Maryland" }, { "city": "Long Branch", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01565291" } ] }